These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

903 related items for PubMed ID: 10485720

  • 21. Antiretroviral interventions for preventing breast milk transmission of HIV.
    White AB, Mirjahangir JF, Horvath H, Anglemyer A, Read JS.
    Cochrane Database Syst Rev; 2014 Oct 04; 2014(10):CD011323. PubMed ID: 25280769
    [Abstract] [Full Text] [Related]

  • 22. Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials.
    Six Week Extended-Dose Nevirapine (SWEN) Study Team, Bedri A, Gudetta B, Isehak A, Kumbi S, Lulseged S, Mengistu Y, Bhore AV, Bhosale R, Varadhrajan V, Gupte N, Sastry J, Suryavanshi N, Tripathy S, Mmiro F, Mubiru M, Onyango C, Taylor A, Musoke P, Nakabiito C, Abashawl A, Adamu R, Antelman G, Bollinger RC, Bright P, Chaudhary MA, Coberly J, Guay L, Fowler MG, Gupta A, Hassen E, Jackson JB, Moulton LH, Nayak U, Omer SB, Propper L, Ram M, Rexroad V, Ruff AJ, Shankar A, Zwerski S.
    Lancet; 2008 Jul 26; 372(9635):300-13. PubMed ID: 18657709
    [Abstract] [Full Text] [Related]

  • 23. Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial.
    Jamieson DJ, Chasela CS, Hudgens MG, King CC, Kourtis AP, Kayira D, Hosseinipour MC, Kamwendo DD, Ellington SR, Wiener JB, Fiscus SA, Tegha G, Mofolo IA, Sichali DS, Adair LS, Knight RJ, Martinson F, Kacheche Z, Soko A, Hoffman I, van der Horst C, BAN study team.
    Lancet; 2012 Jun 30; 379(9835):2449-2458. PubMed ID: 22541418
    [Abstract] [Full Text] [Related]

  • 24. Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine.
    Chung MH, Kiarie JN, Richardson BA, Lehman DA, Overbaugh J, John-Stewart GC.
    AIDS; 2005 Sep 02; 19(13):1415-22. PubMed ID: 16103773
    [Abstract] [Full Text] [Related]

  • 25. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission Mère-Enfant.
    Dabis F, Msellati P, Meda N, Welffens-Ekra C, You B, Manigart O, Leroy V, Simonon A, Cartoux M, Combe P, Ouangré A, Ramon R, Ky-Zerbo O, Montcho C, Salamon R, Rouzioux C, Van de Perre P, Mandelbrot L.
    Lancet; 1999 Mar 06; 353(9155):786-92. PubMed ID: 10459959
    [Abstract] [Full Text] [Related]

  • 26. A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).
    Musoke P, Guay LA, Bagenda D, Mirochnick M, Nakabiito C, Fleming T, Elliott T, Horton S, Dransfield K, Pav JW, Murarka A, Allen M, Fowler MG, Mofenson L, Hom D, Mmiro F, Jackson JB.
    AIDS; 1999 Mar 11; 13(4):479-86. PubMed ID: 10197376
    [Abstract] [Full Text] [Related]

  • 27. Three postpartum antiretroviral regimens to prevent intrapartum HIV infection.
    Nielsen-Saines K, Watts DH, Veloso VG, Bryson YJ, Joao EC, Pilotto JH, Gray G, Theron G, Santos B, Fonseca R, Kreitchmann R, Pinto J, Mussi-Pinhata MM, Ceriotto M, Machado D, Bethel J, Morgado MG, Dickover R, Camarca M, Mirochnick M, Siberry G, Grinsztejn B, Moreira RI, Bastos FI, Xu J, Moye J, Mofenson LM, NICHD HPTN 040/PACTG 1043 Protocol Team.
    N Engl J Med; 2012 Jun 21; 366(25):2368-79. PubMed ID: 22716975
    [Abstract] [Full Text] [Related]

  • 28. Perinatal Antiretroviral Intensification to Prevent Intrapartum HIV Transmission When Antenatal Antiretroviral Therapy Is Initiated Less Than 8 Weeks Before Delivery.
    Lallemant M, Amzal B, Sripan P, Urien S, Cressey TR, Ngo-Giang-Huong N, Klinbuayaem V, Rawangban B, Sabsanong P, Siriwachirachai T, Jarupanich T, Kanjanavikai P, Wanasiri P, Koetsawang S, Jourdain G, Le Coeur S, PHPT-5 site investigators.
    J Acquir Immune Defic Syndr; 2020 Jul 01; 84(3):313-322. PubMed ID: 32205720
    [Abstract] [Full Text] [Related]

  • 29. Interventions for preventing late postnatal mother-to-child transmission of HIV.
    Horvath T, Madi BC, Iuppa IM, Kennedy GE, Rutherford G, Read JS.
    Cochrane Database Syst Rev; 2009 Jan 21; 2009(1):CD006734. PubMed ID: 19160297
    [Abstract] [Full Text] [Related]

  • 30. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
    Kumwenda NI, Hoover DR, Mofenson LM, Thigpen MC, Kafulafula G, Li Q, Mipando L, Nkanaunena K, Mebrahtu T, Bulterys M, Fowler MG, Taha TE.
    N Engl J Med; 2008 Jul 10; 359(2):119-29. PubMed ID: 18525035
    [Abstract] [Full Text] [Related]

  • 31. Effect of zidovudine treatment in late pregnancy on HIV-1 in utero transmission.
    Taneepanichskul S, Sirinavin S, Phuapradit W, Chaturachinda K.
    Aust N Z J Obstet Gynaecol; 1997 Aug 10; 37(3):329-31. PubMed ID: 9325519
    [Abstract] [Full Text] [Related]

  • 32. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS, Dokubo EK, Sint TT.
    Cochrane Database Syst Rev; 2010 Mar 17; (3):CD008440. PubMed ID: 20238370
    [Abstract] [Full Text] [Related]

  • 33. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.
    Dabis F, Bequet L, Ekouevi DK, Viho I, Rouet F, Horo A, Sakarovitch C, Becquet R, Fassinou P, Dequae-Merchadou L, Welffens-Ekra C, Rouzioux C, Leroy V, ANRS 1201/1202 DITRAME PLUS Study Group.
    AIDS; 2005 Feb 18; 19(3):309-18. PubMed ID: 15718842
    [Abstract] [Full Text] [Related]

  • 34. A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.
    Samuel R, Paredes R, Parboosing R, Moodley P, Singh L, Naidoo A, Gordon M.
    J Med Virol; 2015 Oct 18; 87(10):1662-7. PubMed ID: 25940687
    [Abstract] [Full Text] [Related]

  • 35. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F.
    PLoS Med; 2007 Aug 18; 4(8):e257. PubMed ID: 17713983
    [Abstract] [Full Text] [Related]

  • 36. Maternal anaemia and duration of zidovudine in antiretroviral regimens for preventing mother-to-child transmission: a randomized trial in three African countries.
    Sartorius BK, Chersich MF, Mwaura M, Meda N, Temmerman M, Newell ML, Farley TM, Luchters S, Kesho Bora Study Group.
    BMC Infect Dis; 2013 Nov 06; 13():522. PubMed ID: 24192332
    [Abstract] [Full Text] [Related]

  • 37. A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers.
    Gray GE, Urban M, Chersich MF, Bolton C, van Niekerk R, Violari A, Stevens W, McIntyre JA, PEP Study Group.
    AIDS; 2005 Aug 12; 19(12):1289-97. PubMed ID: 16052084
    [Abstract] [Full Text] [Related]

  • 38. Single-dose Nevirapine during pregnancy.
    Sax PE.
    AIDS Clin Care; 1999 Oct 12; 11(10):84-5. PubMed ID: 11366708
    [Abstract] [Full Text] [Related]

  • 39. Nevirapine: a review of its use in the prevention and treatment of paediatric HIV infection.
    Bardsley-Elliot A, Perry CM.
    Paediatr Drugs; 2000 Oct 12; 2(5):373-407. PubMed ID: 11022799
    [Abstract] [Full Text] [Related]

  • 40. Preventing HIV infection in infants in developing countries: NIAID's role. National Institute of Allergy and Infectious Diseases.
    NIAID AIDS Agenda; 1997 Nov 12; ():1-2, 9-10. PubMed ID: 11364919
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 46.